On this page
⚠ Educational content only Not medical or genetic advice. Speak with a healthcare provider or genetic counsellor before acting on anything here.

MMAA

metabolism of cobalamin associated A

The MMAA gene is responsible for producing a protein that plays a crucial role in the body's metabolism of vitamin B12 (cobalamin), particularly in the formation of adenosylcobalamin, a coenzyme essential for certain metabolic processes. The MMAA gene provides instructions for a protein that facilitates the proper utilisation of vitamin B12 within cells.

Chromosome 4q31.21 Autosomal recessive HGNC:18871 Tier C
MMAA 4q31.21 p arm q arm 4

MMAA is located on the long (q) arm of chromosome 4, at band 4q31.21. Arm ratio per GRCh38 - banding schematic.

Explore chromosome 4 in the library →

Available at Jeen Health

Clinical tests that include this

Overview

The MMAA gene, also known as metabolism of cobalamin associated A, encodes a protein involved in the complex biochemical pathway of vitamin B12 (cobalamin) metabolism. This pathway is critical for numerous cellular functions, including energy production and amino acid breakdown. The protein produced from the MMAA gene is particularly important for the synthesis of adenosylcobalamin, a specific form of vitamin B12 coenzyme.

What the gene does

The MMAA protein is involved in the formation of adenosylcobalamin (AdoCbl), a crucial compound derived from vitamin B12. AdoCbl is a necessary coenzyme for methylmalonyl CoA mutase, an enzyme that assists in breaking down certain proteins, fats, and cholesterol. Research indicates that the MMAA protein may contribute to one of the final steps in AdoCbl formation, specifically by transporting vitamin B12 into the mitochondria, which are the energy-producing centres within cells. Within the mitochondria, further chemical reactions convert vitamin B12 into AdoCbl. Additionally, some studies suggest that the MMAA protein might help stabilise methylmalonyl CoA mutase, thereby protecting the enzyme from inactivation and ensuring its continued function.

Video: Genetics 101

Chromosome location

The MMAA gene is situated on the long arm of chromosome 4, specifically at position 4q31.21. This chromosomal location indicates where the gene is found within the human genome. The gene spans a specific region on this chromosome, contributing to the genetic blueprint of an individual.

Protein structure

The MMAA protein comprises 418 amino acids. Domain architecture has not been experimentally characterised in detail for this protein, however, its functional role is known to be associated with vitamin B12 metabolism.

Key variants

Genetic variations within the MMAA gene can affect the protein's ability to properly metabolise vitamin B12. These variants can include changes that alter single amino acids, or larger alterations such as deletions, insertions, or duplications of genetic material within the gene. Such changes can impair the function of the MMAA protein, leading to metabolic disruptions.

The table below shows the top 10 pathogenic or likely-pathogenic variants currently classified in ClinVar for MMAA.
View all on ClinVar →

Sample of pathogenic variants

10 pathogenic / likely-pathogenic variants from ClinVar, ranked by review status (expert-panel-reviewed first). This is a sample; recurrent founder variants in a specific population may not appear here - see the full ClinVar listing via the link above.

Variant (HGVS) Protein change Classification Evidence Associated condition
c.1087C>T
single nucleotide variant
p.Gln363Ter Pathogenic/Likely pathogenic ★★☆☆ Methylmalonic aciduria, cblA type
c.1098G>A
single nucleotide variant
p.Trp366Ter Pathogenic/Likely pathogenic ★★☆☆ Methylmalonic aciduria, cblA type
c.1114C>T
single nucleotide variant
p.Gln372Ter Pathogenic/Likely pathogenic ★★☆☆ Methylmalonic aciduria, cblA type
c.1117G>T
single nucleotide variant
p.Glu373Ter Pathogenic ★★☆☆ Methylmalonic aciduria, cblA type
c.365T>C
single nucleotide variant
p.Leu122Pro Pathogenic/Likely pathogenic ★★☆☆ Methylmalonic aciduria, cblA type
c.388del
Deletion
p.His130fs Pathogenic ★★☆☆ Methylmalonic aciduria, cblA type
c.443T>A
single nucleotide variant
p.Leu148Ter Pathogenic ★★☆☆ Methylmalonic aciduria, cblA type
c.545_546dup
Duplication
p.Ser183fs Pathogenic/Likely pathogenic ★★☆☆ Methylmalonic aciduria, cblA type
c.639del
Deletion
p.Arg214fs Pathogenic/Likely pathogenic ★★☆☆ MMAA-related disorder
c.733+1G>T
single nucleotide variant
- Pathogenic/Likely pathogenic ★★☆☆ Methylmalonic aciduria, cblA type

Evidence stars indicate ClinVar review status. Individual variant interpretation should always be performed by a qualified clinical laboratory - many variants remain classified as Variants of Uncertain Significance (VUS) pending more research.

Associated conditions

Variants in the MMAA gene are associated with methylmalonic acidaemia. This condition is characterised by metabolic difficulties that can lead to feeding issues, developmental delay, and a range of long-term health problems. It is an inherited metabolic disorder that impacts how the body processes certain fats and proteins.

No condition pages are linked to this gene yet. This does not mean it has no associated conditions.

Inheritance pattern

Conditions caused by pathogenic MMAA variants typically follow autosomal recessive inheritance.

♀ Carrier parent 1 altered copy ♂ Carrier parent 1 altered copy Affected Carrier Carrier Unaffected Affected Carrier Unaffected Circles = females · Squares = males

When both parents are carriers, each child has a 25% chance of being affected, 50% of being a carrier, and 25% of being unaffected.

Carrier frequency by population How common is heterozygous MMAA carrier status across ancestry groups?

UK clinical status

The MMAA gene is included in several UK NHS national genomic test directories, indicating its clinical relevance in the UK. It is listed on panels such as DDG2P, Hyperammonaemia, Intellectual disability, Likely inborn error of metabolism, and Undiagnosed metabolic disorders, all of which are classified as 'green' indicating high evidence for clinical utility. For the 'Likely inborn error of metabolism' panel, it specifically falls under R98.

Frequently asked questions

What is the primary function of the MMAA gene?

The MMAA gene provides instructions for a protein crucial in forming adenosylcobalamin (AdoCbl) from vitamin B12. AdoCbl is a coenzyme required for the methylmalonyl CoA mutase enzyme, which breaks down certain fats and proteins.

What condition is associated with variants in the MMAA gene?

Variants in the MMAA gene are associated with methylmalonic acidaemia, a metabolic disorder that can cause feeding difficulties, developmental delay, and long-term health issues.

How is the MMAA gene relevant in UK clinical settings?

In the UK, the MMAA gene is part of several NHS national genomic test directories, including panels for conditions like Hyperammonaemia and Intellectual disability, highlighting its importance in diagnosing specific inherited metabolic disorders.

References

  1. Froese DS, Kochan G, Muniz JR. Structures of the human GTPase MMAA and vitamin B12-dependent methylmalonyl-CoA mutase and insight into their complex formation. The Journal of biological chemistry. 2010. PMID: 20876572
  2. Hörster F, Baumgartner MR, Viardot C. Long-term outcome in methylmalonic acidurias is influenced by the underlying defect (mut0, mut-, cblA, cblB). Pediatric research. 2007. PMID: 17597648
  3. Chandler RJ, Venditti CP. Genetic and genomic systems to study methylmalonic acidemia. Molecular genetics and metabolism. 2005. PMID: 16182581
  4. Korotkova N, Lidstrom ME. MeaB is a component of the methylmalonyl-CoA mutase complex required for protection of the enzyme from inactivation. The Journal of biological chemistry. 2004. PMID: 14734568
  5. Yang X, Sakamoto O, Matsubara Y. Mutation analysis of the MMAA and MMAB genes in Japanese patients with vitamin B(12)-responsive methylmalonic acidemia: identification of a prevalent MMAA mutation. Molecular genetics and metabolism. 2004. PMID: 15308131
  6. Lerner-Ellis JP, Dobson CM, Wai T. Mutations in the MMAA gene in patients with the cblA disorder of vitamin B12 metabolism. Human mutation. 2004. PMID: 15523652
  7. Dobson CM, Wai T, Leclerc D. Identification of the gene responsible for the cblA complementation group of vitamin B12-responsive methylmalonic acidemia based on analysis of prokaryotic gene arrangements. Proceedings of the National Academy of Sciences of the United States of America. 2002. PMID: 12438653
  8. Adam MP, Bick S, Mirzaa GM. Isolated Methylmalonic Acidemia. 1993. PMID: 20301409
Educational content. This page is not medical or genetic advice, is not individually reviewed by a clinician for each reader, and should not replace a consultation with a qualified healthcare professional or genetic counsellor. If you are considering genetic testing or acting on a test result, book a consultation.
Data sources Last updated 18 October 2026. Content compiled from HGNC · MedlinePlus Genetics · ClinGen · Genomics England PanelApp · NHS National Genomic Test Directory · ClinVar · UniProt · AlphaFold .